serum institute of india covid 19 vaccine

WHO Welcomes India’s COVID-19 Vaccine Approval

Initial Findings on ‘Adverse Event’ Didn’t Necessitate Halting of Vaccine Trials, Says Centre

Serum Institute Insists Vaccine Candidate Is ‘Safe’, Trial Participants Are Wary